Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gastman

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Dermatology|December 15, 2018
Histopathologic correlation of high-risk MelaFind<sup>TM</sup> lesions: a 3-year experience from a high-risk pigmented lesion clinicVikas Shrivastava, Phillip Bailin, Jennifer Elliott, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.
Surgical Innovation|June 28, 2013
A modified approach to component separation using biologic graft as a load-sharing onlay reinforcement for the repair of complex ventral herniaDevinder P Singh, Hamid R Zahiri, Brian Gastman, et al.
Cancer Medicine|July 20, 2024
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapiesDanai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, et al.
Annals of Plastic Surgery|April 28, 2006
Conversion Furlow palatoplasty: salvage of speech after straight-line palatoplasty and "incomplete intravelar veloplasty"Negin Noorchashm, Jason R Dudas, Matthew Ford, et al.
Cancer Immunology, Immunotherapy : CII|December 16, 2018
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γLin Lin, Patricia Rayman, Paul G Pavicic, et al.
Journal of Cutaneous Pathology|April 16, 2020
Targeted next generation sequencing (NGS) to classify melanocytic neoplasmsSamaneh K Zarabi, Elizabeth M Azzato, Zheng Jin Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with MelanomaAlan Shen, Michelle Arbesman, Roshan Lodha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2020
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2Jose A Morillas, Francisco Marco Canosa, Pavithra Srinivas, et al.
Journal of the American Academy of Dermatology|June 2, 2015
Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapyBindu V Manyam, Brian Gastman, Alexandra Y Zhang, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Dermatology|December 15, 2018
Histopathologic correlation of high-risk MelaFind<sup>TM</sup> lesions: a 3-year experience from a high-risk pigmented lesion clinicVikas Shrivastava, Phillip Bailin, Jennifer Elliott, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.
Surgical Innovation|June 28, 2013
A modified approach to component separation using biologic graft as a load-sharing onlay reinforcement for the repair of complex ventral herniaDevinder P Singh, Hamid R Zahiri, Brian Gastman, et al.
Cancer Medicine|July 20, 2024
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapiesDanai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, et al.
Annals of Plastic Surgery|April 28, 2006
Conversion Furlow palatoplasty: salvage of speech after straight-line palatoplasty and "incomplete intravelar veloplasty"Negin Noorchashm, Jason R Dudas, Matthew Ford, et al.
Cancer Immunology, Immunotherapy : CII|December 16, 2018
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γLin Lin, Patricia Rayman, Paul G Pavicic, et al.
Journal of Cutaneous Pathology|April 16, 2020
Targeted next generation sequencing (NGS) to classify melanocytic neoplasmsSamaneh K Zarabi, Elizabeth M Azzato, Zheng Jin Tu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with MelanomaAlan Shen, Michelle Arbesman, Roshan Lodha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 2, 2020
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2Jose A Morillas, Francisco Marco Canosa, Pavithra Srinivas, et al.
Journal of the American Academy of Dermatology|June 2, 2015
Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapyBindu V Manyam, Brian Gastman, Alexandra Y Zhang, et al.
Pageof 7